Related content

Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib

By Andtbacka Robert   Ng Chaan   Scaife Courtney   Cormier Janice   Hunt Kelly   Pisters Peter   Pollock Raphael   Benjamin Robert   Burgess Michael   Chen Lei   Trent Jonathan   Patel Shreyaskumar   Raymond Kevin   Feig Barry  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 14-24

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib as first-line neoadjuvant therapy in two patients with rectal stromal tumors

By Weidong Gan   Feng Qu   Xitai Sun   Xiang Yan   Hongqian Guo   Ruipeng Jia  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1697-1701

Future Medicine

Access to resources Recommend Favorite

Efficacy and safety of sunitinib in Chinese patients with imatinib-resistant or -intolerant gastrointestinal stromal tumors

By Li Jian   Gao Jing   Hong Jinlin   Shen Lin  

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 617-624

Future Medicine

Access to resources Recommend Favorite

Management of gastrointestinal stromal tumors

By Rajendra Rajeev   Pollack Seth M   Jones Robin L  

Future Oncology, Vol. 9, Iss. 2, 2013-02 ,pp. : 193-206

Future Medicine

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite